News & Resources
Decode taps new precision medicine data-sharing partner
Precision medicine analytics company Decode Health is entering into a data-sharing partnership with data exchange platform Briya.
As Seen In
Illuminating an Invisible Epidemic: A Systematic Review of the Clinical and Economic Benefits of Early Diagnosis and Treatment in Inflammatory Disease and Related Syndromes
A long sought-after goal across a wide range of healthcare specialties is to devise strategies that enhance patient care and simultaneously reduce expenses. Inflammatory diseases and chronic syndromes currently impose an immense social and economic burden on society in terms of both direct and indirect healthcare costs. While published annual [read more...]
Decode Health Selected As 2023 Best In Business Awards Finalist By Nashville Business Journal
Decode Health, a precision medicine analytics company, was recently announced as a 2023 Best in Business Awards finalist by Nashville Business Journal (NBJ).
Decode Health and Briya Announce Partnership to Advance Precision Medicine through Decentralized Data Exchange
Decode Health, a Nashville based precision medicine analytics company, and Briya, an end-to-end decentralized data exchange platform also based in Nashville with offices in Tel Aviv, today announced a partnership to accelerate innovation projects that seek to improve patient outcomes and advance precision medicine.
Decode Health: Advancing Precision Medicine to Improve Lives
Current methods of managing healthcare are unsustainable, with chronic disease treatment alone putting a $4 trillion annual strain on the U.S. economy. Healthcare professionals across the board agree that earlier diagnosis, better preventative care, and improved disease management will significantly reduce those costs while improving the lives of millions of Americans. In a healthcare landscape rapidly moving towards personalized patient care, precision medicine offers a unique solution.
RNA Genomics: A Powerful Tool to Improve Population Health Management
Autoimmune diseases, such as multiple sclerosis (MS), ulcerative colitis, Crohn’s disease, and rheumatoid arthritis, are complex diseases that affect over four million people in the United States and cost the healthcare system over $90 billion annually. Autoimmune comorbidities present serious complications, increase hospitalization risks, and ultimately amplify the costs associated [read more...]
Battling the Economic Toll of SARS-CoV-2 with Predictive Analytics
According to an article in the Journal of the American Medical Association (JAMA), two Harvard economists estimate the cumulative financial costs of the COVID-19 pandemic at more than $16 trillion. To put this number into perspective, that’s approximately 90% of annual GDP of the United States or $200,000 for a family of four. This is a combination of lost income due to the COVID-induced recession and the economic effect of a shorter, less healthy life.
Using Predictive Community Insights to Slow COVID-19 Hospitalizations
Just as national health officials warned ahead of the holiday season, the winter months of 2020-21 have proven to be the most challenging period of the COVID-19 pandemic so far. In Tennessee alone, there have been more than 10,000 deaths and nearly 18,000 hospitalizations resulting from SARS-CoV-2 infection. At distinct [read more...]